A Phase 1b, Multicentre, Open Label, Study of the Efficacy, Safety and Tolerability of R131 Ointment in Women with Cytological Abnormalities of the Uterine Cervix

This study is currently recruiting participants.

Primary Objective: This study aims to investigate efficacy, safety and tolerability of R131 vaginal ointment in women with low grade and high grade cervical intraepithelial neoplasia (CIN) who have been diagnosed with Human papilloma virus (HPV).

Principal Investigator: Amanda Tristram

Study Coordinator: Michelle Hennessy

Trial Website: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=376148



This study is in start-up.

Principle Investigator: Amanda Tristram

Study Coordinator: Marina Dzhelali

Last updated 25 November 2019.